$BKSY
BlackSky Technology Inc.

2020 Q4 Form 10-Q Financial Statement

#000119312520294734 Filed on November 16, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2020 Q2
Revenue $0.00 $5.317M $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.972M
YoY Change
% of Gross Profit
Research & Development $68.00K
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $474.4K $7.040M $198.4K
YoY Change
Operating Profit -$12.54M -$198.4K
YoY Change 1181426.86% 19368.3%
Interest Expense $72.06K $784.0K $53.52K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$13.92M $85.38K $53.52K
YoY Change
Pretax Income -$14.33M -$13.91M -$144.9K
YoY Change 1311021.58% 14116.39%
Income Tax $4.300K $0.00 -$30.42K
% Of Pretax Income
Net Earnings -$14.33M -$14.42M -$114.4K
YoY Change 1359183.69% 11130.91%
Net Earnings / Revenue -271.24%
Basic Earnings Per Share -$0.42
Diluted Earnings Per Share -$362.5K -$0.42 -$230.9K
COMMON SHARES
Basic Shares Outstanding 39.53M 34.26M shares 39.53M
Diluted Shares Outstanding 34.26M shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $399.5K $501.9K $702.6K
YoY Change
Cash & Equivalents $5.098M $9.356M
Short-Term Investments
Other Short-Term Assets $345.8K $392.9K $253.9K
YoY Change
Inventory
Prepaid Expenses $90.42K $137.5K $253.9K
Receivables $2.903M
Other Receivables
Total Short-Term Assets $18.24M $894.8K $956.5K
YoY Change 1318.03%
LONG-TERM ASSETS
Property, Plant & Equipment $20.85M
YoY Change
Goodwill $9.393M
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.277M $318.0M $318.3M
YoY Change
Other Assets $1.661M $4.300K $880.00
YoY Change
Total Long-Term Assets $101.7M $318.0M $318.3M
YoY Change -67.92%
TOTAL ASSETS
Total Short-Term Assets $18.24M $894.8K $956.5K
Total Long-Term Assets $101.7M $318.0M $318.3M
Total Assets $119.9M $318.9M $319.3M
YoY Change -62.32% 67553.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.177M $1.873M $25.00K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue $14.54M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $16.74M
YoY Change
Total Short-Term Liabilities $55.44M $1.873M $367.6K
YoY Change 19961.3% 314.9%
LONG-TERM LIABILITIES
Long-Term Debt $84.87M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.605M $11.07M $11.07M
YoY Change
Total Long-Term Liabilities $88.47M $11.07M $11.07M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $55.44M $1.873M $367.6K
Total Long-Term Liabilities $88.47M $11.07M $11.07M
Total Liabilities $152.7M $12.94M $11.44M
YoY Change 1246.2%
SHAREHOLDERS EQUITY
Retained Earnings -$224.0M -$585.1K $1.283M
YoY Change -64331.06% 11468.72%
Common Stock $3.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$32.81M -$22.71M $5.000M
YoY Change
Total Liabilities & Shareholders Equity $119.9M $318.9M $319.3M
YoY Change -62.32% 67553.14%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income -$14.33M -$14.42M -$114.4K
YoY Change 1359183.69% 11130.91%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$142.4K -$590.6K -$664.9K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $40.00K $390.0K $283.9K
YoY Change
Cash From Investing Activities $40.00K $390.0K $283.9K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -142.4K -590.6K -664.9K
Cash From Investing Activities 40.00K 390.0K 283.9K
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash -102.4K -200.6K -381.0K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$142.4K -$590.6K -$664.9K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Cash
Cash
501925
CY2019Q4 us-gaap Cash
Cash
1083611
CY2020Q3 us-gaap Assets
Assets
318908762
CY2019Q4 us-gaap Assets
Assets
318245958
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1873034
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
276368
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5584194
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4650349
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
5000010
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
318908762
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
318245958
CY2020Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2205105
CY2019Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1061
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2661813
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2881
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-1868373
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1061
us-gaap Net Income Loss
NetIncomeLoss
-933862
us-gaap Net Income Loss
NetIncomeLoss
-2881
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9411691
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6875000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9403795
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7353480
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
202472
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
181732
CY2020Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-936801
CY2020Q3 us-gaap Assets Current
AssetsCurrent
894796
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
94636
CY2020Q3 sftwu Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
11068750
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
5000004
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1048954
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-114443
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
22823
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-801
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-1019
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
5000009
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
5000004
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
22022
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
21003
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
19942
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1255546
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2516
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
91740
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4140
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-581686
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6656
CY2018Q4 us-gaap Cash
Cash
42061
CY2019Q3 us-gaap Cash
Cash
35405
sftwu Deferred Offering Costs Included In Accrued Offering Costs
DeferredOfferingCostsIncludedInAccruedOfferingCosts
171966
CY2020Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
137507
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1286083
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4300
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1361
CY2020Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
318009666
CY2019Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
316958514
CY2020Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1873034
CY2019Q4 sftwu Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
11068750
CY2020Q3 us-gaap Liabilities
Liabilities
12941784
CY2019Q4 us-gaap Liabilities
Liabilities
11345118
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-585146
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
348716
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2205105
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1061
us-gaap Operating Income Loss
OperatingIncomeLoss
-2661813
us-gaap Operating Income Loss
OperatingIncomeLoss
-2881
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
101658
us-gaap Investment Income Interest
InvestmentIncomeInterest
1745490
CY2020Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-16279
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-20478
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
85379
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1725012
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2119726
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1061
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
255364
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
350000
us-gaap Revenues
Revenues
0
CY2020Q3 sftwu Operating Bank Accounts
OperatingBankAccounts
501925
CY2020Q3 sftwu Marketable Securities Held In Trust
MarketableSecuritiesHeldInTrust
318009666
CY2020Q3 sftwu Working Capital Deficit
WorkingCapitalDeficit
1203602
CY2020Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
30000
CY2020Q3 us-gaap Prepaid Taxes
PrepaidTaxes
255364
CY2020Q3 sftwu Deposit In The Trust
DepositInTheTrust
1760000
dei Security12b Title
Security12bTitle
Units, each consisting of oneshare of Class A common stock, $0.0001 par value per share, and one-half of one redeemable warrant.
dei Trading Symbol
TradingSymbol
SFTWU
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2020Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
255364
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the condensed financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
sftwu Public Shares Redemption Percentage
PublicSharesRedemptionPercentage
1.00
us-gaap Related Party Transaction Terms And Manner Of Settlement
RelatedPartyTransactionTermsAndMannerOfSettlement
The Promissory Note was non-interest bearing and payable on the earlier of December 31, 2019 or the completion of the Initial Public Offering.
us-gaap Decommissioning Trust Assets Description
DecommissioningTrustAssetsDescription
<div style="margin-bottom: 0pt; font-size: 10pt; font-family: times new roman; margin-top: 12pt">The Sponsor and the Company&#8217;s officers and directors have agreed (a)&#160;to waive their redemption rights with respect to their Founder Shares and Public Shares held by them in connection with the completion of a Business Combination and (b)&#160;not to propose an amendment to the Company&#8217;s Amended and Restated Certificate of Incorporation (a)&#160;that would modify the substance or timing of the Company&#8217;s obligation to allow redemption in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (b)&#160;with respect to any other provision relating to stockholders&#8217; rights or pre-initial Business Combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
sftwu Description Of Minimum Votes To Be Polled
DescriptionOfMinimumVotesToBePolled
These provisions of the Company&#8217;s Amended and Restated Certificate of Incorporation may only be amended if approved by holders of a majority of at least 90% of the Company&#8217;s common stock voting in a stockholder meeting.<table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7906250
CY2019Q4 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
1409901
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2881
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-251353
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2939
sftwu Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
1745490
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-20478
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2939
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-64965
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1691302
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
365
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-94636
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
673860
sftwu Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
933868
sftwu Minimum Percentage Of Fair Market Value Of Business Acquisition To Trust Account Balance
MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance
0.80
sftwu Business Acquisition Percentage Of Minimum Ownership To Be Acquired
BusinessAcquisitionPercentageOfMinimumOwnershipToBeAcquired
0.50
sftwu Public Shares Redemption Percentage Threshold
PublicSharesRedemptionPercentageThreshold
0.15
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1031250
CY2020Q3 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
80743
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
1409901
CY2020Q3 sftwu Net Loss Adjusted
NetLossAdjusted
-1949116
CY2019Q3 sftwu Net Loss Adjusted
NetLossAdjusted
-1061
sftwu Net Loss Adjusted
NetLossAdjusted
-2343763
sftwu Net Loss Adjusted
NetLossAdjusted
-2881
CY2020Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7906250
CY2020Q1 sftwu Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
-1048949
CY2020Q2 sftwu Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
114438
CY2020Q3 sftwu Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
1868379
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
673860
CY2020Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
300966968
CY2019Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
301900836
CY2020Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
29908965
CY2019Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
30142702
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
80743
CY2019Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1581250
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
87600
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
39531250
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Registrant Name
EntityRegistrantName
Osprey Technology Acquisition Corp.
dei Entity Central Index Key
EntityCentralIndexKey
0001753539
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA

Files In Submission

Name View Source Status
0001193125-20-294734-index-headers.html Edgar Link pending
0001193125-20-294734-index.html Edgar Link pending
0001193125-20-294734.txt Edgar Link pending
0001193125-20-294734-xbrl.zip Edgar Link pending
d19358d10q.htm Edgar Link pending
d19358dex311.htm Edgar Link pending
d19358dex312.htm Edgar Link pending
d19358dex321.htm Edgar Link pending
d19358dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sftwu-20200930.xml Edgar Link completed
sftwu-20200930.xsd Edgar Link pending
sftwu-20200930_cal.xml Edgar Link unprocessable
sftwu-20200930_def.xml Edgar Link unprocessable
sftwu-20200930_lab.xml Edgar Link unprocessable
sftwu-20200930_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending